WELG:XETRA:XETRA-Amundi S&P Global Health Care ESG UCITS ETF DR EUR Inc (EUR)

ETF | Others |

Last Closing

USD 11.382

Change

+0.08 (+0.67)%

Market Cap

USD 0.25B

Volume

5.40K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-03-28 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.60 (+1.20%)

USD 450.46B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.19 (+1.23%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.24 (+0.94%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.31 (+1.15%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.27 (+1.14%)

USD 157.79B
TM5:XETRA T-MOBILE US INC.DL-00001

-0.52 (-0.34%)

USD 126.93B
8R80:XETRA Amundi Index Solutions - Amund..

+2.54 (+1.86%)

USD 104.09B
JARI:XETRA Amundi Index Solutions - Amund..

+0.38 (+0.89%)

USD 101.29B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.60 (+1.21%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+10.20 (+2.07%)

USD 80.38B

ETFs Containing WELG:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.23% 70% C- 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.23% 70% C- 70% C-
Trailing 12 Months  
Capital Gain 16.50% 63% D 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.50% 63% D 65% D
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 1.86% 43% F 42% F
Dividend Return 1.86% 42% F 40% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 4.33% 87% B+ 90% A-
Risk Adjusted Return 42.82% 59% D- 61% D-
Market Capitalization 0.25B 54% F 48% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.